a rendering of pancreatic cancer cells Credit: LASZLO / Adobe Stock A discovery about how pancreatic cancer spreads could lead to better therapies for the hard-to-treat disease, which kills more than 50,000 people in the US every year. Researchers are already testing an existing drug, used for organ transplants, to stop the cancer’s spread. The challenge: Pancreatic cancer is relatively rare, accounting for just 3% of cancers diagnosed in the US, but it’s notoriously hard to beat — 88% of patients die within five years of finding out that they have the disease. A major reason for the low survival...